GIA announces the release of a comprehensive global report on Veterinary Vaccines markets. Global market for Veterinary Vaccines is forecast to reach US$9.0 billion by 2020, buoyed by resurgence in global trade, emerging pet industry in the developing countries, increased animal movement and the subsequent emergence of animal diseases.
San Jose, California (PRWEB) March 10, 2014
Fueled by the high prevalence of diseases in livestock herds and pets, and the continuous emergence of newer strains of pathogens, demand for veterinary vaccines is expected to register significant growth over the coming years. Extensive scientific R&D on animal diseases and new biotechnological vaccine offerings is expected to further strengthen market growth. In developing countries, pet industry is gaining popularity due to socioeconomic development. This creates a huge market for companion animal/pet vaccines. In addition, dietary patterns in developing countries are shifting towards animal protein, which is resulting in increased livestock production and more demand for vaccines that prevent diseases.
Food safety concerns in the developed countries are creating strong demand for bovine vaccines which prevent beef/dairy cattle herd diseases. New-age poultry vaccines which can be administered in-ovo are seeing increased acceptance among poultry breeders. Veterinary vaccines help cut down economic losses for livestock breeders and pet owners. Recombinant technology is expected to play a significant role in the development of genetically engineered veterinary vaccines which provide higher and longer-lasting immunity with fewer shots as compared to the traditional vaccines.
As stated by the new market research report on Veterinary Vaccines, the United States and Europe represent the largest markets worldwide. Asia-Pacific and Latin America are spearheading global growth backed by China and Brazil. Growth in these developing countries is attributed to an emerging pet industry and increased demand for livestock output in terms of meat, milk, and eggs. China represents the fastest growing veterinary vaccines market globally with a compounded annual growth rate of 10.8% over the analysis period.
Livestock vaccines represent the largest segment in the market. The segment is buoyed by changing dietary patterns, and rising preference for animal protein and protein products. In addition, the massive global destruction caused by the Foot-and-Mouth Disease (FMD) among cattle herds resulted in increased research on the disease and the quest for an effective vaccine. Among livestock vaccines, porcine vaccines comprise the largest segment. China is one of the largest pork producers in the world and is expected to significantly contribute to the porcine vaccine market. The wide-spread global outbreak of avian influenza during the past decade significantly contributed to the growth and development of the poultry vaccine market. In the companion animal vaccines market, canine vaccines represents the largest segment with growth led by the rapidly growing pet market in emerging economies. The need to raise safe and healthy pets will promote growth in the market in the coming years.
Major players covered in the report include Bayer Healthcare AG, Biogenesis-Bago, Boehringer Ingelheim GmbH, Ceva Santé Animale, Heska Corporation, Indian Immunologicals Ltd., Lohmann Animal Health, Merck Animal Health, Merial Ltd., Protein Sciences Corporation, Virbac SA, Zoetis Inc., among others.
The research report titled “Veterinary Vaccines: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, growth drivers, segmental analysis, regulations, mergers, acquisitions, and other strategic industry activities of major global players. The report provides market estimates and projections for all major geographic markets, such as the US, Europe (France, Germany, Italy, UK, Spain, and Rest of Europe), Asia-Pacific (China and Rest of Asia-Pacific), and Latin America (Brazil and Rest of Latin America). Product segments analyzed in the report include Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, and Other Livestock Vaccines).
For more details about this comprehensive market research report, please visit –
http://www.strategyr.com/Veterinary_Vaccines_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/
Follow us on LinkedIn. Reported by PRWeb 12 hours ago.
San Jose, California (PRWEB) March 10, 2014
Fueled by the high prevalence of diseases in livestock herds and pets, and the continuous emergence of newer strains of pathogens, demand for veterinary vaccines is expected to register significant growth over the coming years. Extensive scientific R&D on animal diseases and new biotechnological vaccine offerings is expected to further strengthen market growth. In developing countries, pet industry is gaining popularity due to socioeconomic development. This creates a huge market for companion animal/pet vaccines. In addition, dietary patterns in developing countries are shifting towards animal protein, which is resulting in increased livestock production and more demand for vaccines that prevent diseases.
Food safety concerns in the developed countries are creating strong demand for bovine vaccines which prevent beef/dairy cattle herd diseases. New-age poultry vaccines which can be administered in-ovo are seeing increased acceptance among poultry breeders. Veterinary vaccines help cut down economic losses for livestock breeders and pet owners. Recombinant technology is expected to play a significant role in the development of genetically engineered veterinary vaccines which provide higher and longer-lasting immunity with fewer shots as compared to the traditional vaccines.
As stated by the new market research report on Veterinary Vaccines, the United States and Europe represent the largest markets worldwide. Asia-Pacific and Latin America are spearheading global growth backed by China and Brazil. Growth in these developing countries is attributed to an emerging pet industry and increased demand for livestock output in terms of meat, milk, and eggs. China represents the fastest growing veterinary vaccines market globally with a compounded annual growth rate of 10.8% over the analysis period.
Livestock vaccines represent the largest segment in the market. The segment is buoyed by changing dietary patterns, and rising preference for animal protein and protein products. In addition, the massive global destruction caused by the Foot-and-Mouth Disease (FMD) among cattle herds resulted in increased research on the disease and the quest for an effective vaccine. Among livestock vaccines, porcine vaccines comprise the largest segment. China is one of the largest pork producers in the world and is expected to significantly contribute to the porcine vaccine market. The wide-spread global outbreak of avian influenza during the past decade significantly contributed to the growth and development of the poultry vaccine market. In the companion animal vaccines market, canine vaccines represents the largest segment with growth led by the rapidly growing pet market in emerging economies. The need to raise safe and healthy pets will promote growth in the market in the coming years.
Major players covered in the report include Bayer Healthcare AG, Biogenesis-Bago, Boehringer Ingelheim GmbH, Ceva Santé Animale, Heska Corporation, Indian Immunologicals Ltd., Lohmann Animal Health, Merck Animal Health, Merial Ltd., Protein Sciences Corporation, Virbac SA, Zoetis Inc., among others.
The research report titled “Veterinary Vaccines: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, growth drivers, segmental analysis, regulations, mergers, acquisitions, and other strategic industry activities of major global players. The report provides market estimates and projections for all major geographic markets, such as the US, Europe (France, Germany, Italy, UK, Spain, and Rest of Europe), Asia-Pacific (China and Rest of Asia-Pacific), and Latin America (Brazil and Rest of Latin America). Product segments analyzed in the report include Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, and Other Livestock Vaccines).
For more details about this comprehensive market research report, please visit –
http://www.strategyr.com/Veterinary_Vaccines_Market_Report.asp
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/
Follow us on LinkedIn. Reported by PRWeb 12 hours ago.